Quantum BioPharma Submits IND for Lucid-MS Trial
TORONTO, April 1, 2026 Quantum BioPharma Ltd. announced the submission of an Investigational New Drug (IND) application to the...
GLP
Advertisement
InnoCan Secures FDA CVM Waiver for LPT-CBD Drug
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
MSD Animal Health Data Confirms Efficacy of Intranasal Bovine Coronavirus Vaccine
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
Allosite Therapeutics Showcases Novel Integrin Therapies at ASN 2025
Miami, Florida – October 30, 2025 — Allosite Therapeutics, a biotechnology company pioneering allosteric integrin agonists for the treatment...
Advertisement
